Journey Medical CorporationDERMNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank73
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P73
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM-1.19%+92.0%
2024-14.96%-716.5%
20232.43%+107.7%
2022-31.47%+39.4%
2021-51.90%-349.2%
202020.83%+13.0%
201918.44%+103.8%
2018-485.46%+92.5%
2017-6491.57%-1577.1%
2016-387.08%-